Sort
39,280 grants matching “leukemia”
Reprogram long-lived effector T cells for cancer immunotherapy
$594,393Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2020 · CA
Molecular Diagnosis and Prognosis in Aggressive Lymphoma
$594,380Lisa Rimsza · University Of Arizona · U01 · FY2012 · CA
Alternative RNA splicing and protein products in leukemia outcome (PQ11)
$594,337Scott A. Ness · University Of New Mexico Health Scis Ctr · R01 · FY2012 · CA
Gene Regulation By Steroid Receptor Proteins
$594,289Keith Robert Yamamoto · University Of California, San Francisco · R01 · FY2014 · CA
Molecular Control of Plasmacytoid Dendritic Cell Development and Function
$594,130Boris Reizis · New York University School Of Medicine · R37 · FY2018 · AI
Molecular Control of Plasmacytoid Dendritic Cell Development and Function
$594,130Boris Reizis · New York University School Of Medicine · R37 · FY2019 · AI
HIV Gag lattice morphology and particle biogenesis
$594,114Louis M Mansky · University Of Minnesota · R01 · FY2017 · GM
DEVELOPING NOVEL IMMUNOTHERAPEUTICS FOR ACUTE MYELOID LEUKEMIA
$593,996University Of Southern California · · FY2019 · Department of the Army
COG NCTN Network Group Operations Center
$593,811Peter C Adamson · Children'S Hosp Of Philadelphia · U10 · FY2015 · CA
The role of cytotoxic T cells in rheumatoid arthritis pathogenesis
$593,736Felipe Andrade · Johns Hopkins University · R01 · FY2022 · AR
Targeting PRC1 in leukemia
$593,733Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Identification of novel biomarkers and therapeutic strategies in chemobrain.
$593,672Mi-Hyeon Jang · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA
Identification of novel biomarkers and therapeutic strategies in chemobrain.
$593,617Mi-Hyeon Jang · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA
DNA Methylation Canyons in Human Cancers: Methods, Target Genes and Functional Consequences
$593,614Wei Li · Baylor College Of Medicine · R01 · FY2019 · CA
Project 1: Effects of inflammation on clonal competition and malignant transformation
$593,496Katherine Yudeh King · Baylor College Of Medicine · P01 · FY2022 · CA
Genomics of Acute myelogenous leukemia (AML): Whole Genome Resequencing
$593,403Richard K. Wilson · Washington University · P01 · FY2009 · CA
Glia maturation factor-gamma modulation of signaling pathways in macrophages
$593,389Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Targeting Notch2 in Hematopoietic Cell Therapy.
$593,369Lan Zhou · Case Western Reserve University · R01 · FY2020 · HL
Targeting Notch2 in Hematopoietic Cell Therapy.
$593,369Lan Zhou · Case Western Reserve University · R01 · FY2021 · HL
HIV Gag lattice morphology and particle biogenesis
$593,325Louis M Mansky · University Of Minnesota · R01 · FY2018 · GM
A Testing Program to Identify Novel Agents for Treatment of Pediatric and AYA High-Risk Sarcoma, Kidney and Liver Cancer
$593,085Raushan Kurmasheva · University Of Texas Hlth Science Center · U01 · FY2024 · CA
A Testing Program to Identify Novel Agents for Treatment of Pediatric and AYA High-Risk Sarcoma, Kidney and Liver Cancer
$593,085Raushan Kurmasheva · University Of Texas Hlth Science Center · U01 · FY2025 · CA
Development of Inhibitors of the Leukemia Fusion Protein CBFbeta-SMMHC
$593,059John Hackett Bushweller · University Of Virginia · R01 · FY2013 · CA
Occupational and Environmental Determinants of Cancer among Women and Minorities
$592,815Jonathan Hofmann · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Molecular Epidemiology of NHL and CLL
$592,731Mayo Clinic · R01 · FY2004 · CA